Introduction
As early as 1899, Edmund Wilson reviewed cellular organization as visualized by light microscopy and wrote " […] the background of all phenomena appears to lie in the invisible organization of as ubstance which seems to the eye homogeneous." [1] Although it was not known that proteins and RNAf orm most of the "substance," it was intuitive that this substance was organized.
Indeed, we know today that living matter is not am ere Brownian soup of molecules.I nstead, these molecules assemble with each other to give rise to adynamic machinery of exquisite complexity.I nt his Review,w ea pproach the concept of self-organization by focusing on protein selfassembly.W ed istinguish between two main types of assemblies:p rotein complexes that are finite, [2] and potentially infinite assemblies that we term "agglomerates" (see the Glossary). Theassembly of proteins into finite complexes has long been viewed as afundamental level of organization, and today we know thousands of such complexes. [3, 4] In contrast, polymeric assemblies that are potentially infinite have been classically viewed as restricted to specific sets of proteins,such as those forming the cytoskeleton. [5] However,wewill see that numerous reports have been shifting this paradigm in recent years.
In this Review,w ef irst contrast agglomeration and aggregation. Aggregation is sometimes viewed as the only process by which proteins can accidentally form supramolecular polymers in vitro or in vivo.W ew ill see,h owever, that agglomeration can also occur readily,both in the test tube and during evolution (Section 2). Thep otential of proteins to agglomerate is largely dependent on the properties of their surfaces and on their internal symmetry.T his dependencyi s the focus of Section 3. In the following two sections,w e review instances of naturally occurring protein agglomerates observed in the context of diseases (Section 4) and in the context of normal cellular functions (Section 5). Lastly,w e review how agglomeration has been harnessed by chemists and protein engineers in the design of open-ended protein assemblies (Section 6). Throughout the Review,w eplace an emphasis on protein symmetry,w hich is ac ommon theme unifying all these aspects of agglomeration.
Agglomeration as aF requent Process Distinct from Aggregation

Agglomeration versus Aggregation
Thespontaneous assembly and precipitation of proteins is frequently observed when increasing their concentration, changing solvent conditions,o rw hen mutations are introduced. [6] [7] [8] [9] It is typical to think of such precipitates as aggregates (see the Glossary), whereby apartially or entirely misfolded form of the protein drives its association into highorder assemblies.
However,t he accidental assembly of proteins does not necessarily involve misfolding.I nstead, it may result from associations between folded proteins.Although several terms may be used to describe such as cenario,f or example, "Protein Xassembles into large structures in which it remains folded" or "Protein Xp olymerizes while remaining folded"
Mutations and changes in aproteinsenvironment are well known for their potential to induce misfolding and aggregation, including amyloid formation. Alternatively,such perturbations can trigger new interactions that lead to the polymerization of folded proteins.I n contrast to aggregation, this process does not require misfolding and, to highlight this difference,w er efer to it as agglomeration. This term encompasses the amorphous assembly of folded proteins as well as the polymerization in one,t wo,o rthree dimensions.W es tress the remarkable potential of symmetric homo-oligomers to agglomerate even by single surface point mutations,a nd we review the double-edged nature of this potential:how aberrant assemblies resulting from agglomeration can lead to disease,but also howa gglomeration can serve in cellular adaptation and be exploited for the rational design of novel biomaterials.
these cannot be conveniently used as verbs to describe the process and do not capture the idea of an accidental occurrence.T his led us to use "agglomeration" as at ermwhich sounds similar to "aggregation" and can be employed succinctly and generically as av erb,f or example,"Protein X agglomerates"-to describe aprocess of infinite,folded-state assembly.Analternative could be "Protein Xadopts aquinary structure," although this term has been associated to more transient and heterogeneous protein assemblies [10] and does not reflect apossible accidental or pathological nature in the way aggregation or agglomeration do.
At as tructural level, native contacts are lost in aggregation and are replaced by non-native contacts,w hereas in agglomeration, native contacts preserve the structure of the surface(s) that interact to drive assembly.I nb oth processes, we consider af inite protein unit or protomer [11] (see the Glossary) as as tarting point and define aggregation or agglomeration as the transition from af inite to an openended, potentially infinite assembly.Such transitions could be triggered by aperturbation such as amutation [7, 12] or achange in the proteinse nvironment. [7, 13] We illustrate seven transitions in Figure 1 , each involving ad ifferent path. These examples show acontinuum between pure aggregation, where all native contacts are lost in the assembly,a nd pure agglomeration, where all native contacts are preserved:
1. An increased self-interaction potential leads to the nonordered (amorphous) agglomeration of ah omodimer. Such aprocess can be employed to purify active forms of Comparing agglomeration and aggregation. In biology,aggregation is concomitantt oaloss of structure, in the form of partial or complete unfolding. [7] [8] [9] Thus, the term aggregation is misleading when describing aprocess where proteins assemble in their folded state. The illustration shows both processes with seven examples of transitions from closed (finite) to open-ended (infinite)a ssemblies, each described in the main text (Section 2.1). Each transition is characterized by apathway with two components:m isfolding/folding of the protomers (x-axis), and orderliness of the assemblies formed (y-axis). Fors implicity,the same dimeric unit is depicted as astarting point in transitions 1-5, but the symmetry of the dimer is only essential for driving transitions 2a nd 3. proteins by "salting them out" using high concentrations of kosmotropic agents such as ammonium sulfate. [14, 15] 2. As pecific self-interaction is gained, which drives the ordered assembly of ah omodimer into ar egular and potentially infinite filament. Such as cenario is seen, for example,i nt he sickle cell disease [16] or in the S134N and apo-H46R mutants of superoxide dismutase (SOD). [17] 3. Part of the structure of the dimer is destabilized, which induces domain swapping with another dimer. Thedomain swapping creates an ew self-interaction and drives,a sin example 2, the formation of an infinite filament. This scenario is halfway between aggregation and agglomeration, since misfolding is required, but filament assembly also depends on the dimer retaining most of its native contacts.S uch as cenario is seen in filaments formed by phage T7 endonuclease I, for example. [18] 4. Part of the structure of adimer is destabilized, unfolds,and self-interacts to form across-beta-sheet amyloid structure. In contrast to example 3, the unfolded part directly mediates the self-association and assembly,w hich does not involve the native contacts.S uch filaments are seen with ribonuclease A [19] or b-lactoglobulin filaments,f or example. [20] 5. Thes tructure or part of the structure of ad imeric unit unfolds,a nd the residues exposed interact across units to drive the formation of an amorphous aggregate.H ere,a s well, the native contacts do not mediate the assembly.This is typically seen in thermal denaturation, for example. [21] 6. Thee quilibrium between unfolded and folded states of ap olypeptide chain is concentration-dependent, with the latter being stabilized by homo-oligomerization. Homomer units form at high peptide concentrations and subsequently assemble into acrystal lattice.Such abehavior has been observed in designed peptides that selfassemble into apredefined lattice. [22] 7. Ad isordered protein self-associates and forms an amorphous assembly.N either agglomeration nor aggregation would be an appropriate term to describe such atransition as no misfolding is necessarily required and yet the polypeptide chains are not folded. Numerous reports of such transitions have been described recently,w here intrinsically disordered proteins phase-separate under specific conditions. [23] This transition could be referred to as "phase separation,"a lthough this term is general and applies to other transitions presented Figure 1 . Alternatively,"condensation" could be employed. [23] Theterms "amyloid" and "aggregate" are sometimes used to describe assemblies of folded proteins, [24] but this conveys an inaccurate picture.Indeed, making the distinction between assemblies of folded versus misfolded proteins is key because their molecular origin, their formation mechanism, and their cellular consequences are expected to differ: * Aggregation is associated with changes in protein stability, [8, 9] whereas agglomeration is dependent on the surface properties of the protein. [12, 25] * Aggregation involves conformational changes,w hich can dramatically shape the energy landscape of the aggregate growth. [26, 27] Activation energy is indeed required to drive partial unfolding, [28] and to cross anucleation barrier in the case of amyloid formation. [8] In contrast, the activation energy required for agglomeration drives the disruption of the structured water shell around the protomers. [29] Additionally,t he growth of an agglomerate can involve an ucleation barrier (e.g.a si nc rystal formation [29] )o r could be isodesmic, [26] and thereby not involve anucleation barrier. In relation to these differences,a ggregates are typically irreversible [7] -for example,t hey only resolubilize on addition of denaturants or detergents-whereas agglomeration has often been described as being reversible ( Figure 2 ). [12, 13, 30] * As to the consequences,m isfolding exposes hydrophobic segments that are normally buried and these can recruit chaperones. [31, 32] In contrast, agglomeration does not involve the exposure of such segments and, thus,i sn ot expected to recruit chaperones.
Despite these differences at the molecular level, agglomerates and aggregates exhibit similar macroscopic phenotypes:both are visible to the naked eye through turbidity and precipitation in vitro (Figure 2) . Similarly,i nvivo,a gglomerates can cluster into punctate foci [12] of similar appearance to those formed by aggregates. [33] Such similarities stress further the need for different terminologies to avoid confounding both processes.
Natural Proteins Are Prone to Self-Interact
Thei ntrinsic potential of proteins for self-association leading to agglomeration has been exploited in purification procedures for several decades. [15] In these procedures, proteins are fractionated by high concentrations of kosmotropic salts, [14] most notably ammonium sulfate.A lso called "salting-out,"t his process increases the surface tension of water, [34] thus favoring interactions between folded proteins and their precipitation. [15] Thep redisposition of proteins for self-interaction is perhaps best reflected in X-ray crystallography experiments, where fortuitous self-interactions must form ac rystal lattice. [35] Thus,t he success of crystallography underlines that protein surfaces are naturally prone to self-associate.T his idea is confirmed when comparing the chemical composition of protein-protein interfaces (see the Glossary) and solventexposed surface patches.T he composition of these two surface types differs,o na verage,b yo nly two amino acid substitutions [36] and highlights that protein surfaces are naturally "sticky."
To investigate this stickiness potential, Garcia-Seisdedos et al. examined whether mutations solely designed to increase the surface hydrophobicity of dihedral complexes would often trigger their agglomeration by stacking. All 12 homomers examined underwent agglomeration following the introduction of one to four point mutations, [12] thus confirming that protein surfaces evolve on the verge of self-assembly ( Figure 3 ). Also consistent with this idea is that solely reducing the rotational entropy of ap rotein by am agnetic field directed its self-assembly into 2D arrays, [37] which shows that the enthalpic component of the association free energy was naturally favorable. In fact, the natural stickiness of protein surface patches can be aburden that needs to be counterbalanced by negative design, whereby specific physicochemical properties evolve to minimize the formation of alternative,unwanted structures. [38] Forexample,from the law of mass-action, proteins expressed at high levels in cells are more likely to engage in promiscuous interactions than lowly expressed proteins and, accordingly, their surface shows reduced hydrophobicity. [25] Negative design can thus be detected on specific proteins but also at sensitive locations on their surface (Figure 3b )toreduce their potential for mis-assembly. [12, 39] 
Agglomeration in
Relation to Protein Quaternary Structure
Thes ymmetry of ap roteinsquaternary structure has ad ramatic impact on its potential to agglomerate.T his connection was described formally by Monod and co-workers. [40] Theu nderlying concepts are described in this section. We also refer the reader to ar eview by Yeates and co-workers,w hich describes geometry and symmetry rules underlying finite versus infinite protein assembly. [41] 3.1.
Symmetry of Protein Quaternary Structures
In homo-oligomers or "homomers," all protomers [30] b) Avariant of GFP displaying anet charge of + 36 interacts with anionic tRNAs and precipitates. These agglomerates reversibly dissociate upon screening charge-charge interactions with salt. [30] c) Ah omo-octamer with dihedral symmetry agglomerates through hydrophobic surface interactions. This associationi sreversible, being induced in the presence of salt and repressedi nits absence. [12] d) The yeast protein ADE4 (involved in adenine biosynthesis) clusters in response to specific stresses, includingadenine depletion. [13] This mechanism is reversible upon repleting the growth media. Images reproduced from Ref. [30] [(a) and (b), https://pubs.acs.org/doi/full/10.1021/ja071641y] and Ref. [13] with permission [(d), Copyright2 009, NationalA cademy of Sciences]. Figure 3 . Increasing surface hydrophobicity triggers supramolecular self-assembly and is counterbalanced by negative design. a) Topand second row: structure solved by X-ray crystallography of four homomers with dihedral symmetry.The corresponding PDB codes are indicated at the top. Shown underneath are fluorescence microscopy images of yeast cells expressingthe wild-type homomers fused to ayellow fluorescentprotein. The localization is cytoplasmic and homogeneous. The following row shows yeast cells expressingm utant proteins in which surface hydrophobicity was increasedb ypoint mutations (shown in red in the structures).T he two right-most mutants formed fibers and the two left-mostf ormed foci. The last row shows transmission electron microscopy (TEM) images with negative staining for the same mutants, which stack into filaments. [12] b) The tip regions of homomersw ith dihedral symmetry were termed "geometric hot spots" because mutations in those regions triggered agglomeration more frequently than surface mutations away from them. [12] Among natural homomers with dihedral symmetry,g eometric hot spots were enriched with charged and hydrophilic amino acids relative to the rest of the protein surface. [12] Reproduced from Ref. [12] with permission [(a), Copyright 2017, Springer Nature].
are identical in sequence and consequently-as was suggested by Caspar and Klug [42] -are generally equivalent in terms of their structure and geometry.I no ther words,they tend to all exist in achemically identical environment. Only rotation point group symmetries (cyclic,d ihedral, and cubic) satisfy this equivalence constraint ( Figure 4 ). These symmetry types are frequent:about 65 %(E. coli) and about 45 % (H. sapiens) of proteins of known structure adopt ap oint group symmetry ( Figure 4 ). Ah omomer with cyclic symmetry composed of n protomers (denoted C n )s hows as ingle n-fold symmetry axis.H omomers with dihedral symmetry can be viewed as two cyclic complexes stacked "back-toback,"a nd thus are composed of m = 2 n protomers (denoted D m )r elated by one n-fold symmetry axis and n 2-fold axes ( Figure 4) . Lastly,the cubic group includes tetrahedral, octahedral, and icosahedral symmetries,w hich are described further in the literature. [42] [43] [44] Ah allmark of point group symmetries is that all symmetry axes pass through, and intersect at, the center of mass.I tf ollows that such homomers are only composed of rotational symmetries and never of translational symmetries.
Homotypic and Heterotypic ProteinProtein Interfaces
Protein assembly requires the formation of interfaces with energetically favorable interactions,t he physicochemical properties of which have been extensively studied and reviewed. [44] [45] [46] [47] [48] [49] In this subsection, we focus on two properties of interfaces that are particularly relevant when rationalizing the formation of open-ended assemblies:1)the distinction between homotypic and heterotypic interfaces (see the Glossary), and 2) the potential of protein surfaces to form either type.
Homotypic interfaces involve two identical surfaces interacting with twofold symmetry ( Figure 5a ). Thus,a ny dimer with C 2 symmetry involves ah omotypic interface.H eterotypic interfaces are formed when two distinct Figure 4 . Point group symmetries of homomers and their frequency among proteins of known structure. The frequency of each symmetry type is shown for proteins from E. coli and H. sapiens,based on apreviously published dataset containing homomers from both species. [25] The inset illustrates the arrangement of protomers in cyclic, dihedral, and cubic point group symmetries. surface patches are in contact, as happens in hetero-oligomers and in cyclization events with three or more protomers. [2] For example,acyclic homomer with C 4 symmetry involves four protomers interacting "face-to-back" (Figure 5b ).
Thed istinction between homotypic and heterotypic interfaces is fundamental because of the energetic implications.I nh omotypic interfaces,e ach amino acid residue is repeated twice by symmetry,s oi ts contribution to the free energy of association is more likely to be extreme on average (i.e.h ighly favorable or highly unfavorable) when compared to heterotypic interfaces,w here each amino acid is present once only. [50, 51] Consequently,i nascenario where interfaces are randomly created and where stable ones are selected, homotypic interfaces will be selected more frequently than heterotypic ones, [52] [53] [54] which possibly accounts for the high frequency of homotypic interactions in natural homomers. [55] 
From aFinite Complex to an Agglomerate
Aprotomer which can interact with itself will form anew assembly,t he properties of which depend on several parameters:1)the starting quaternary structure (see the Glossary), 2) the type of interface gained, and 3) the location of the interface gained on the protomerss tructure.A ss tarting quaternary structures,wedistinguish monomers,cyclic homomers,a nd higher order symmetries (dihedral and cubic). For the descriptions below we refer the reader to Figure 5c: * Upon gaining an ew heterotypic interaction, am onomer adopts ac losed symmetry (e.g. C 1 !C 3 ). Alternatively,i t can form infinite filaments that are straight (e.g. C 1 ! filament) or contain ah elical component (not shown). Upon gaining ahomotypic interface,however,amonomer necessarily yields aclosed dimer (C 1 !C 2 ). * Starting from ac yclic homomer,f urther assembly into afinite complex is possible and can involve the creation of both homotypic and/or heterotypic interfaces.T he geometry of the new interfaces,h owever, is decisive in determining the type of the resulting assembly.F or example,the gain of ahomotypic interface yields adihedral symmetry if it occurs at the top or bottom parts of the ring (e.g. C 3 !D 3 ), but may also yield an infinite planar assembly if occurring at another location (e.g. C 4 !plane). * Lastly,s tarting from ah omomer with dihedral or cubic symmetry,t he gain of any new interface-either homotypic or heterotypic-will necessarily result in the formation of an open, infinite assembly (e.g.
Given these geometric determinants,and considering the energetic advantage of homotypic interfaces over heterotypic ones (Section 3.2), we anticipate that natural open-ended assemblies will often stem from homomers with dihedral symmetry.
Agglomeration and Disease
Different Modes of Agglomeration Observed with Hemoglobin
Then otion that homomers with dihedral symmetry are only one self-interaction away from forming agglomerates (Section 3.3) suggests that some disease mutations could be linked to agglomeration. Indeed, aw ell-known example of agglomeration is that of hemoglobin in the sickle cell disease. As ingle glutamate-to-valine mutation on the hemoglobin surface causes this pathology. [16, 56] In the deoxygenated form, mutant hemoglobin tetramers assemble into rigid filaments and deform the shape of the red blood cells.T he process is reversible as,u pon reoxygenation, the filaments rapidly dissolve,w hich allows cells to recover their typical shape. [16] Thef ilamentous agglomeration of hemoglobin is tied to its C 2 (pseudo-D 2 )s ymmetry:t he mutation E6V at the b subunit surface induces its interaction with ac opy of itself, and repeating this interaction through symmetry drives the formation of af ilament (Figure 6a ). Interestingly,alysine mutation at the same residue (E6) can cause another type of agglomeration, where oxyhemoglobin forms intracellular crystals associated with hemolytic anemia in homozygous patients. [57, 58] Although the agglomeration of hemoglobin is associated with pathologies in humans,red blood cells in some species of deer naturally exhibit asickle shape.The sickling mechanism was recently also attributed to ag lutamate-to-valine change, albeit in adifferent part of the structure. [59] In contrast to the human case,d eer hemoglobin also agglomerates in the oxygenated form.
Other Agglomeration-Associated Diseases
Agglomeration has been related to pathologies other than the sickle cell. In congenital cataracts,c rystallins in the eye lens form large assemblies that scatter light, thus creating opaqueness that leads to blindness.S uch assemblies can be triggered by environmental stress,m etabolic imbalance,o r mutations. [60] TheP 23T mutation on g-d-crystallin, for example,t riggers the amorphous assembly of folded crystallins (Figure 6b ), which indicates agglomeration rather than aggregation. [61, 62] In another example,Kmoch et al. described amutation (R36S) that induces g-d-crystallin to assemble into small crystals visible in the eye lens (Figure 6c) . [63] The pathological consequences of agglomeration in the sickle cells and cataracts are both linked to physical properties of the agglomerates themselves,w hich disrupt cell shape or light propagation. In numerous other cases,the impact of agglomerates on cellular functions is less well understood.
Mutations in the enzyme superoxide dismutase (SOD1) are linked to amyotrophic lateral sclerosis (ALS), [64] adegenerative disease of the human motor system. Since Rosen et al. first characterized am utation in SOD1 associated with ALS over two decades ago, [64] more than 150 disease-related mutants have been identified. Nonetheless,t he molecular mechanisms underlying the pathology remain unclear. While Angewandte Chemie Reviews 5520 www.angewandte.org the loss of dismutase activity has been postulated to be apossible cause, [65, 66] the prevalent view is that cytotoxicityis related to misfolding and aggregation of SOD1 mutants. [67] It is noteworthy,h owever,t hat many of the "aggregates" reported are agglomerate-like,whereby SOD1 self-assembles in alargely folded state. [17, [68] [69] [70] Similarly,c ytidine triphosphate synthase (CTPS,F igure 6d)a nd inosine monophosphate dehydrogenase (IMPDH) are two enzymes central to nucleotide biosynthesis that form filamentous agglomerates in various organisms, including humans. [71, 72] Their polymerization upregulates their enzymatic activity, [73, 74] and the fact that cancer cells display high levels of CTPS and IMPDH activities [75, 76] begs the question of an association between their filamentous agglomeration and cancer metabolism and proliferation. Chang et al. recently found that CTPS filaments appear to be substantially enriched in cancerous hepatocytes [71] and are associated with high levels of the heat shock protein 90 (HSP90), thus hinting at ap ossible metabolic adaptation mechanism in hepatocellular carcinoma.
In another example,a gglomerates of lithostatine (Figure 6e) were observed in early onset deposits of Alzheimers disease. [77, 78] More intriguing, 20-40 %o fpatients treated for chronic inflammation associated with hepatitis Cv irus infection develop auto-antibodies recognizing filamentous agglomerates of the protein IMPDH1. [79] Interestingly,mutations on the same IMPDH1 enzyme (R224P and D226N) are associated with the autosomal dominant disease retinitis pigmentosa, one of the main causes of visual handicap in developed countries. [80] IMPDH1 mutants seem to exhibit the same enzymatic activity as the wild-type.H owever,asubstantial decrease in protein solubility has been reported, which suggests apossible association between agglomeration and pathology. [80] 4.3. Agglomeration as aM eans To Control Drug Release Thereversible nature of agglomerates has been harnessed as aw ay to control drug release.R ivera et al. engineered synthetic proteins consisting of insulin fused to tandem repeats of an FKBP12 mutant protein exhibiting aw eak dimerization tendency. Dimerization events across multiple polypeptide chains led to amorphous agglomeration by phase separation in am anner described recently, [84] and those agglomerates were sequestered in the endoplasmic reticulum. Thei nhibition of FKBP dimerization with as mall molecule would then dissolve the agglomerates and allow insulin release in acontrolled fashion. [85] Agglomeration of insulin to slow down its release into the blood has been exploited in multiple strategies.I no ne strategy,t hree mutations were engineered to induce insulin assembly at neutral pH after injection, whereas insulin would remain soluble at pH 4i nt he formulation. [86, 87] In an alternative strategy,i nsulin agglomeration was achieved by covalent modifications of asurface-exposed lysine residue: [88] acylation at lysine 29 with af atty diacid (hexadecanedioic acid linked through a g-l-glutamate) promoted the stacking of hexamers into filaments termed multihexamers.Inhibition Figure 6 . Open-ended assemblies related to ad isease.a )The mutation E6V triggers the formation of filaments in human deoxyhemoglobin, which causes the sickle cell disease. The Figure shows double strands of hemoglobinS(E6V) tetramersrevealed by crystallography. [81] b) The mutation P23T on g-d-crystallin monomers induces their amorphous agglomeration, here visualized by EM with negative staining. [61, 62] c) The mutation R36S on g-d-crystallin monomers induces their crystallization. Crystals accumulate in the eye lens and cause cataracts. The crystals of g-d-crystallin R36S in phosphate-buffered saline (PBS) are imaged by inverse light microscopy. [63] d) Cytidine triphosphatesynthase (CTPS) is an enzyme with D 2 symmetry capable of assembling into filaments. The cryo-EM reconstruction of ahuman CTPS is shown. [73] e) Lithostatine is amonomeric protein that forms D 2 tetramers after autoproteolysis. The image shows lithostatine protofibrils characterized by AFM. [77, 82] f) Zinc promotes insulin to form hexamers, which further assemble into filaments by introducing acovalent modification (purple). Filament formation was dependent on phenol and is visualized here by EM with negative staining. [83] Reproducedf rom Ref. [ of the stacking by phenol maintained insulin in al ow molecular weight form before injection, but diffusion of phenol in the subcutaneous environment allowed insulin to polymerize into a" molecular depot" (Figure 6f ). Subsequently,progressive diffusion of zinc allowed disassembly and slow diffusion of insulin monomers into the blood. [83, 89] 
Agglomeration of Natural Proteins
Agrowing number of studies are identifying proteins that agglomerate in response to environmental stresses [90] [91] [92] such as starvation, [13, [93] [94] [95] heat shock, [96] or DNAdamage. [97] These assemblies often form in areversible manner (Figure 2d ), [13, 96] thus suggesting ar ole in cellular adaptation. It is also noteworthy that many of these assemblies form through ap rocess of phase separation, ap henomenon that is stimulating aparadigm shift in the way we view and conceive proteome organization. [23, 98] Importantly,t he definitions of agglomeration and phase separation converge for some systems (e.g. salting out of proteins [99] ). There is,h owever, one notable difference:i na gglomeration, the identity and structure of protomers are well-defined, whereas in phaseseparation, protomers can show large conformational and compositional heterogeneity. [23, 84] 
Symmetry in Natural Filamentous Agglomerates
As we saw in Figure 5a nd Section 3, symmetry is intimately tied to the formation of open-ended assemblies. To highlight this notion, we reviewed filamentous assemblies (Table 1 ) and identified the quaternary structure found in each assembly.Although monomers represent 35 %and 55 % of proteins of known structure in E. coli and H. sapiens, respectively (Figure 4) , [43, 55, 100] less than 10 %o ft he proteins listed in Table 1are monomeric themselves.Incontrast, while only about 15 %o fh omomers of known structure show ad ihedral symmetry, [55, 100] more than 60 %o ft he proteins listed in Table 1d o. This over-representation of internally symmetric complexes reflects the ease with which homotypic interfaces can evolve (Section 3.2) and that new self-interactions among dihedral homomers often yield filamentous agglomerates (Section 3.3).
Agglomeration and Protein Function
Agglomeration can be induced solely by changes in the environment, [101, 102] thus making it afast and energy-efficient mechanism for stress response compared to transcription. [90, 92] In particular,a gglomerates can serve as molecular depots of inactive enzymes that can be disassembled when conditions allow growth [93] or ametabolic activity such as photosynthesis to be resumed. [103] Forexample,starvation induces glutamine synthetase in S. cerevisiae to assemble into catalytically inactive filaments. [93] Although the molecular mechanisms for the formation of filament and punctate structures upon entry into the stationary phase are largely uncharacterized, it was found that acidification of the cytoplasm can be atrigger in numerous cases, [101] and co-solutes may also play arole. [104] Thef act that filaments frequently occur upon nutrient depletion is consistent with a" molecular depot" function. Nonetheless,f ilament assembly does not necessarily lead to catalytic inactivation. Fore xample,C TPS forms filaments that are catalytically active in eukaryotes and inactive in prokaryotes. [73, 105, 106] Similarly,I MPDH can assemble into filaments that adopt both active and inactive conformations, shifting from one to the other upon binding to GTP and other substrates. [107] Ap ossible burden for the catalytic function of ap rotein agglomerate is the reduced accessibility of substrates to the active site of the enzyme.H owever,t his handicap can be turned into an asset. In oat b-glycosidase,the active site of the enzyme is located in ac entral tunnel formed by af ilament, and although filament formation limits substrate accessibility, it also limits its diffusion once it enters into the tunnel, thereby resulting in an increased apparent affinity for its natural substrate.Additionally,the filament increases specificity towards the substrates,asthe width of the tunnel acts as amolecular sieve to discriminate the avenacosides from other kinds of b-glucosides. [108] Binding to asubstrate can also trigger filament formation of certain proteins.T wo examples are acetyl-CoA carboxylase (ACC) [109] and phosphofructokinase (PFK1), [110] whose polymerization appears to be promoted by citrate. [109, 111] Similarly, the glutaminase inhibitor BPTES induces the dissociation of the glutaminase Cf ilaments and stabilizes the inactive tetrameric form. [112] 
Agglomeration as aMechanism for Evolutionary Innovation and its Impact on Fitness
Symmetry has long been harnessed by evolution to generate novel folds,a ss een in the TIM barrel and ß-propeller folds,for example. [113, 114] Similarly,inagglomerates, new protein interfaces may create new functionalities such as active sites, [115] as seen in natural enzymes. [116] More intriguingly,G arcia-Seisdedos et al. observed that mutations increasing the surface stickiness of homomers frequently resulted in ac hange of their localization in budding yeast. Whereas all of the wild-type homomers were expressed in the cytosol, numerous point mutants localized to the nucleus and one formed agglomerates localized at the bud neck. [12] These results indicate that proteins can exhibit complex and unexpected behaviors at the cellular level when they agglomerate.
Furthermore,p rotein agglomerates may create opportunities for the colocalization of other macromolecules and, thereby,s eed new functions. [117] More straightforwardly, agglomeration can modulate the availability and function of proteins by sequestering them into ac onfined space.S uch am echanism has been reported for transcription factors containing glutamine-rich repeats.T he expansion of these repeats can induce the transcription factor to self-assemble, thereby decreasing its activity through sequestration. [118] In as imilar vein, agglomerates may form phenotypes with Angewandte Chemie Reviews 5522 www.angewandte.org [17] deleterious functions that sequester molecular species required for normal cellular function.
[119]
Agglomeration for the Design of Biomaterials
Precise control over the structure of materials is acentral goal of materials science.E ither unstructured [127] [128] [129] [130] or fully folded peptides and proteins can be used as building blocks to self-assemble materials from the bottom-up.T he use of agglomeration for the design of materials provides several benefits.F irst of all, folded proteins have aw ell-defined surface topology that enables precise control over the mode of association. Secondly,the retention of the protein fold can confer catalytic or binding properties to the material. Finally, the reversible nature of agglomeration (Figure 2 ) reduces the potential for the formation of kinetically trapped intermediates.A dditionally,r eversibility opens-up am uch bigger opportunity:t he design of dynamic materials capable of shifting morphology and of self-healing. Key to the design of agglomerated state materials are the assembly rules illustrated in Figure 5c and also described in other reviews. [41, 131, 132] Lessons learned from the evolution [36, 55, [133] [134] [135] [136] [137] [138] [139] [140] and from the design [141] [142] [143] [144] [145] of soluble closed-symmetry assemblies can be applied to constructing materials by designing outward-facing interfaces,thus creating assemblies with open symmetries.
Agglomerates from Coiled-Coil Protomers
Given the central role of point-group symmetry in the formation of infinite assemblies,t he periodic and symmetric structure of coiled coils makes them ideal building blocks for material design. Moreover,the typical sequence length of the peptide chains (25 to 50 amino acids) [146] makes their synthesis attainable by solid-phase methods.T he first example of as ynthetic peptide characterized as forming an open-ended assembly in the folded state was an a-helical coiled coil that stacked into one-dimensional fibers. [147] Although the sequence of this peptide was not selected for self-assembly, the observation that self-assembly was achievable without extensive planning illustrated that agglomeration is ac ommon feature of folded peptides and proteins,a s discussed in Section 2.
Theserendipitous discovery that coiled coils could readily self-assemble led to efforts to design folded-state peptide materials rationally.W oolfson and co-workers rationally designed coiled-coil units with protruding uncomplemented sticky ends for unit-unit interactions,w hich led to their association into filaments. [148] This strategy was widely replicated in the design of biocompatible materials. [146, [149] [150] [151] [152] The assembly of ahelical bundle into filaments by way of surface interactions (as opposed to using "sticky ends") was achieved later. [153] Interestingly,t his assembly was designed to be pHsensitive and provided aproof-of-concept that folded proteins could be designed to self-assemble into open-ended filaments [a] The assemblies listed correspond to those formed by proteins that are ordinarily monomeric or form afinite complex. This table does not consider proteins whose sole functioni nvolves filament formation,s uch as actin or tubulin. The gene name and description of each protein identified as forming filaments are given along with its function, the organism, the corresponding structure in the PDB or,i fonly ahomologueisa vailable,t he percentagesequence identity shared with the homologue. The symmetry of the protein unit forming the filament(or that of the closest homologue)is shown schematically and the method used to detect it indicated (EM:electron microscopy; AFM:a tomic force microscopy; FM:f luorescence microscopy; IFM:i mmunofluorescence microscopy; IHC:i mmunohistochemistry) as well as the culture condition in which the filaments were observed.
[ b] id = identity,NA= not available, Wt = wild-type.
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Reviews 5524 www.angewandte.org by careful consideration of the chemical properties of the surface residues. In the absence of "sticky ends," the hydrophobic positions at both extremities of the coiled-coil bundles provide anatural surface for promoting intermolecular interactions.Conticello et al. exploited this feature to design aheptameric coiled coil prone to self-assemble by end-to-end stacking. [154] Thel arge diameter of the 7-helical oligomer they used created aw ide hydrophobic face on the blunt ends of the bundle which, following surface optimization, self-assembled into infinite fibers.T he fibrils were extensively characterized, and their structure was found to be consistent with stacked heptameric coiled coils.T his design strategy was subsequently used to illustrate that folded proteins can retain their function in the agglomerated state,w ith the design of ah elical bundle capable of self-assembling into fibers while retaining the ability to bind curcumin. [155] Woolfson and co-workers expanded on this strategy and generalized it to coiled coils with different oligomerization states,a sillustrated in Figure 7a,b . [156] This set of coiled coils was further used as afusion to aprotein cage to create aprotein matrix capable of forming in vivo. [157] Theu se of coiled coils as subunits of self-assembling materials has also been applied to two-dimensional and threedimensional arrays.S aven and co-workers used ac omputational approach to identify as equence variant of a3 -helix bundle that would self-interact to form ac rystalline lattice with as pecific geometry (Figure 7g) . [22] This computational approach was also used to design robust arrays of twodimensional helical bundles that could tolerate variability in the solution conditions as well as chemical modification of the termini. [158, 159] 
Agglomerates from Protomers Interacting through Bridging
Notable progress has been achieved through the use of coiled coils as units for self-assembly.H owever,t he limited structural and functional diversity of coiled-coil bundles has motivated the use of naturally occurring proteins as alternative building blocks.I ndeed, naturally occurring proteins offer alarge diversity of shapes and functions,but are difficult to redesign because of their rugged folding landscape and the difficult nature of interface design. Thes trategies reviewed herein circumvent these difficulties and involve little or no surface redesign. Instead, they are based on bridging preexisting symmetric homomers.T he bridges can be very diverse,from small molecules to peptides,orcan be achieved by genetic fusion of two distinct homomers.T he length, branching,a nd flexibility of the bridging species are key in dictating the resulting structure.
In an early example,D otan et al. used al ectin with D 2 symmetry as abuilding block, and atwofold symmetric ligand as ab ridge between them. Mixing the two in 1:2r atio triggered their assembly in adiamond-like geometry. [160] This approach has been formalized and generalized by Yeates and co-workers, [144] who described how 1D,2D, and 3D materials can be assembled depending on the symmetries of the building blocks and that of the bridge. Engineeredagglomerates forming filamentous, planar,amorphous, or crystalline assemblies. a) and b) One-dimensional assemblies from coiled-coil peptide subunits by face-to-back stacking characterized by TEM with negative staining. [156] c) Homomersw ith dihedral symmetry stack following point mutations solely designed to increase their surface hydrophobicity.Stacks were visualized by TEM with negative staining. [12] d) Ac omputationally designed two-dimensional lattice of homomersw ith C 6 symmetry interacting by noncovalent interactions, characterized by TEM with negative staining. [175] e) An auxetic two-dimensional lattice of homomers with C 4 symmetry assembled through disulfide bonds. The assembly is seen by TEM with negative staining. [176] f) Liquid protein droplet assembled from octahedralf erritin subunits harboring acovalent modification mediating ferritin-ferritini nteractions. The droplets were observed by optical microscopy. [165] g) Three-dimensional protein crystal computationally designed from trimeric coiled-coil subunits and assembled by noncovalent interactions. The image shows an electron density map obtained from crystal X-ray diffraction experiments. [22] Images were reproduced from Ref. [156] [(a,b), Copyright 2013, AmericanC hemical
Bridging Protomers with Surface Binders
Molecules capable of binding protein surfaces can serve as bridges to create interactions between subunits.F or example, multivalent cyclic small molecules that bind to specific types of amino acids can serve as versatile molecular glues to induce polymerization. [161, 162] Thes urfaces of protein targets can be modified with non-natural amino acids to serve as recognition elements for such small-molecule polymerizers. [163] In adifferent but related approach, as urface lysine of insulin was covalently modified with ac arbohydrate-binding functional group. [164] Thep resence of ac arbohydrate subsequently allowed multiple hexamers of insulin to bridge with each other, thereby leading to their agglomeration.
Assembly into aLow-Ordered Phase
Highly flexible bridging species will produce only shortrange order and can result in amorphous agglomerates,a si n phase separation. Surface-modified ferritin has been used to create such infinite assemblies displaying short-range order. [165] Fore xample,f erritin was used to create as olventfree protein liquid by chemically modifying its surface to create long-range ionic interactions between the protomers, as illustrated in Figure 7f .
[165a]
Assembly into One-Dimensional and Branched Filaments
Directionality and long-range order can be imposed by rigid linkers.Y eates and co-workers genetically fused two dimeric proteins by ar igid a-helix, the orientation of which was designed to promote one-dimensional propagation. [144] Hayashi and co-workers engineered heme binding proteins covalently bound to heme cofactors. [166] Thecofactor of one unit bound to the heme binding pocket of another unit, thereby resulting in infinite polymerization. Thei ncorporation of three-way linkers with heme moieties allowed for branched propagation. In addition, heteromeric structures composed of myoglobin and streptavidin could be constructed through the use of linkers containing both heme and biotin moieties.
Ward and co-workers also took advantage of the internal D 2 symmetry of streptavidin. They created alinear ligand with biotin groups that dimerized through coordination bonds to iron(II), thus leading to one-dimensional assembly,t he formation of which was dependent on the presence of iron. [167] In ad ifferent approach, Brunsveld and co-workers used aligand capable of stacking into filaments and showed it could act as as caffold for proteins by way of its appended biotin moieties. [168, 169] 
Assembly into Two-Dimensional Lattices
Theformation of long-range order in two dimensions will produce periodic planar lattices.H owever, periodicity over long length scales is difficult to achieve given the potential for the formation of local defects.I nt hat respect, as for onedimensional assembly,t he rigidity and directionality of the linker are of crucial importance.
Ringler and Schulz combined C 4 -symmetric l-rhamnulose-1-phosphate aldolase (RhuA) with D 2 -symmetric streptavidin to build at wo-dimensional material. [170] RhuA was decorated with biotin on its surface to present ab inding interface for streptavidin, which served as abridge to mediate the interaction of RhuA units.The tether to biotin was chosen to be short to maintain the rigidity of the connection and enabled the formation of two-dimensional networks.
Noble and co-workers fused multimeric proteins,w hile considering the compatibility of the internal symmetries in the individual complexes.C omplexes that shared ac ommon symmetry operation were selected so that the large-scale structure of the material could be planned out by specifying the location of each subunit within the 2D lattice. [171] By selecting proteins in orientations that would position the point-of-fusion termini close to an axis for rotation, the size of the fusion linker could be limited to only two amino acids, thus preventing local defects.
Assembly into Three-Dimensional Lattices
As indicated in the introduction of this section, the dihedral symmetry of lectin tetramers has been harnessed in the creation of ad iamond-like protein material. [160] In this design, the length of the linker between the sugar subunits was carefully selected to ensure that no alternative assembly types would be adopted.
Jiang and co-workers cemented the idea that the types of materials that can be obtained depend on the flexibility of the bridging molecule. [172] [173] [174] In one example, D 2 -symmetric lectin subunits were made to associate by way of alinker composed of ag alactose moiety for binding to the lectin as well as arhodamine Bmoiety,which dimerized. Changing the length of the linker between the two moieties shifted the dimensionality of the assembly dramatically and produced oligomerization in one,two,o rthree dimensions. [174] 
Agglomerates of Protomers Interacting through Designed Interfaces
Recently,a dvances in computational modeling and an increased understanding of protein interfaces have enabled the design of protein-based materials by interface design. A protein fiber designed exclusively by mutation was created by Schulz and co-workers. [177] Starting from the cyclic tetramer RhuA, two distinct sets of mutations induced homotypic interactions and stacking into adihedral octamer, either at the top or the bottom surface of RhuA. When the two sets of mutations were combined (i.e.top and bottom together), this led to an open-ended assembly by sequential stacking,a s illustrated in Figure 5c (C 4 !D 4 !filament). Later,G arciaSeisdedos et al. generalized this approach and showed that mutations close to the top-most or bottom-most surface of large dihedral complexes (D 4 and D 5 )and solely designed to increase surface hydrophobicity were often sufficient to trigger stable face-to-face stacking into filaments,v isible both in vitro and in vivo. [12] Similarly,ap rotein of unknown function named Hcp1 was observed to form C 6 homomers Angewandte Chemie Reviews 5526 www.angewandte.org stacking face-to-back in the crystal lattice.M ougous and coworkers stabilized the crystallographic interface using cysteine mutations,w hich led the protein to form nanotubes in solution. [178] Baker and co-workers have used ac omputational approach for the design of materials mediated by interactions between globular protein domains. [175, 179] Fore xample,f rom alibrary of naturally occurring protein complexes with cyclic symmetries,c onfigurations of assemblies within layer space group arrangements with shape complementary of the interface were identified.
[175a] Computational protein design was used to stabilize the selected configurations by mutation. The structure of the lattices,s olved using cryo-EM and electron diffraction, confirmed that the interface geometry could be designed de novo with high precision (Figure 7d ). Remarkably,t his approach relaxes the need for an existing binding site and paves the way to the design of 2D materials with any protein and any desired geometry.
Agglomerates of Protomers Interacting through Designed Metal Coordination and Disulfide Bonds
Te zcan and co-workers pioneered the design of protein assemblies mediated by metal coordination. They were initially able to build several types of assemblies with closed symmetries by introducing novel metal-binding sites on the surface of folded proteins. [180, 181] Thelessons learned from the design of cyclic protein assemblies were then applied to design crystalline materials from natively folded subunits. [182, 183] Dynamic features were also incorporated into crystalline materials. [176] Cysteine residues introduced at the surface of tetrameric RhuA mediated its assembly into atwodimensional lattice upon oxidation (Figure 7e) . Remarkably, these lattices showed dynamic but uniform morphologies, thus indicating that local changes in orientation between RhuA units were able to propagate through the material.
Most recently,T ezcan and co-workers engineered as ystem that allowed reversible ferritin agglomeration. [184] In this system, af erritin variant previously designed to crystallize through engineered calcium binding contacts was used. Crystals of this variant were soaked in as olution of poly(acrylate-acrylamide) precursors,a nd their polymerization formed ah ydrogel matrix within and around the crystals.E xpansion of the hydrogel matrix by water absorption followed by dehydration recovered the original structure of the crystal lattice and even improved the resolution of the X-ray diffraction data. More striking even, the crystal was able to self-heal fractures occurring during the expansion and contraction cycles.
Summary and Outlook
Protein agglomeration connects chemistry and biology through two central features:m acromolecular interactions and symmetry.C ontinued efforts in the characterization of agglomeration will have far-reaching implications for our understanding of protein function and how it impacts cells, both in healthy and diseased organisms.A dditionally,t hese efforts are paving the way for the design of new types of biomaterials. [41, 185, 186] Impressive progress has already been made in the last two decades in terms of agglomerate design, and recent advances in fluorescence microscopy techniques have revealed am ultitude of natural protein agglomerates (Table 1) . Thef unction of these agglomerates and their potential implication in disease remain poorly characterized, in part because of the difficulty in altering ap roteins agglomeration properties in predictable ways.Inthat respect, advances in protein design could drive abetter understanding of agglomerate biology,b ya llowing the design of mutants constitutively promoting or inhibiting assembly,o rb yi dentifying general properties of agglomeration, for example,the fact that agglomerates are highly evolvable from homomers with dihedral symmetry. [12] Conversely,a ssembly rules could be inferred from structural analyses of biological agglomerates,f or example,t o identify how negative design helps funnel the assembly and promote order over long length scales.S uch analyses could also help understand how protein assemblies that are openended can sometimes adopt specific and finite sizes,a si n tripeptidyl peptidase II. [187] When designing functionalized agglomerates,b iological agglomerates may also serve as models to design substrate channels or molecular sieves that increase substrate specificity.I nt hese endeavors,t he molecular basis of agglomerates will need to be characterized, which will be facilitated by the development of new cryoelectron microscopy techniques to characterize protein assemblies in vivo. [188] Lastly,agglomerates can easily be dismissed as artifactual aggregation (e.g. when observing precipitation in vitro or punctate structures in vivo). We hope this Review will stimulate awareness of the existence and high likelihood of the agglomeration process in the protein realm, and prompt scientists to actively characterize any potential forms of agglomeration they encounter in test tubes and living cells. Recently,for example,abacterial protein was found to form cross-a helical stacks reminiscent of-but different from-the classic amyloid structure involving cross-b sheets, [189] which indicates that new and unexpected types of agglomerates are waiting to be discovered.
Glossary
Protein-protein interface:Contact surface between two proteins. Homotypic interface:Interface involving two identical protein surfaces related by atwofold symmetry axis. Heterotypic interface:Interface formed by two distinct protein surfaces. Protomer:Constituent subunit or groups of subunits within aprotein assembly. [11] In ahomodimer,e ach polypeptide chain is ap rotomer. In hemoglobin, each (ab)p air is ap rotomer. Closed assembly or closed symmetry:Protein assembly in which protomers are related by point group rotational symmetry.Such assembly is finite,and all protomers are in equivalent (or quasi-equivalent) chemical environments. Open-ended assembly or open symmetry:P rotein assembly that involves translational symmetry between protomers. Assembly by this mode can continue indefinitely,u nlike closed assembly.Not all protomers are in equivalent chemical environments.Some protomers exhibit unsatisfied interfaces, potentially leading to open-ended (infinite) assembly.
Aggregate:O pen-ended assembly of proteins interacting through misfolded regions. Agglomerate:Open-ended assembly of protomers interacting through surface regions that retain their native or near-native fold upon binding.A lthough the Latin root "glomus" describes aspherical object, we employ agglomerate irrespective of the assembly geometry (amorphous,1 D, 2D,or 3D).
